Inovio Pharmaceuticals Inc (INO)
12.10
+0.09
(+0.75%)
USD |
NASDAQ |
May 03, 16:00
12.12
+0.02
(+0.17%)
After-Hours: 20:00
Inovio Pharmaceuticals Total Assets (Quarterly): 170.95M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 170.95M |
| September 30, 2023 | 193.10M |
| June 30, 2023 | 233.04M |
| March 31, 2023 | 266.58M |
| December 31, 2022 | 348.53M |
| September 30, 2022 | 391.97M |
| June 30, 2022 | 459.40M |
| March 31, 2022 | 445.51M |
| December 31, 2021 | 495.94M |
| September 30, 2021 | 535.76M |
| June 30, 2021 | 591.84M |
| March 31, 2021 | 654.86M |
| December 31, 2020 | 539.77M |
| September 30, 2020 | 437.81M |
| June 30, 2020 | 443.19M |
| March 31, 2020 | 338.92M |
| December 31, 2019 | 143.95M |
| September 30, 2019 | 151.53M |
| June 30, 2019 | 165.07M |
| March 31, 2019 | 191.17M |
| December 31, 2018 | 131.11M |
| September 30, 2018 | 140.70M |
| June 30, 2018 | 148.92M |
| March 31, 2018 | 173.66M |
| December 31, 2017 | 187.24M |
| Date | Value |
|---|---|
| September 30, 2017 | 203.68M |
| June 30, 2017 | 158.85M |
| March 31, 2017 | 153.31M |
| December 31, 2016 | 173.71M |
| September 30, 2016 | 194.55M |
| June 30, 2016 | 203.99M |
| March 31, 2016 | 211.29M |
| December 31, 2015 | 213.84M |
| September 30, 2015 | 230.77M |
| June 30, 2015 | 201.70M |
| March 31, 2015 | 117.86M |
| December 31, 2014 | 131.79M |
| September 30, 2014 | 134.53M |
| June 30, 2014 | 142.15M |
| March 31, 2014 | 151.66M |
| December 31, 2013 | 88.29M |
| September 30, 2013 | 88.02M |
| June 30, 2013 | 50.99M |
| March 31, 2013 | 58.20M |
| December 31, 2012 | 45.14M |
| September 30, 2012 | 44.48M |
| June 30, 2012 | 48.60M |
| March 31, 2012 | 55.35M |
| December 31, 2011 | 61.11M |
| September 30, 2011 | 63.27M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
143.95M
Minimum
Dec 2019
654.86M
Maximum
Mar 2021
368.83M
Average
391.97M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Cerus Corp | 197.75M |
| Stereotaxis Inc | 41.91M |
| Viemed Healthcare Inc | 154.90M |
| AIM ImmunoTech Inc | 19.38M |
| Protalix BioTherapeutics Inc | 84.43M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 53.60M |
| Shareholders Equity (Quarterly) | 117.35M |
| Debt to Equity Ratio | 0.1429 |
| Current Ratio | 3.597 |
| Net Debt Paydown Yield | -0.07% |